Dianliang Napu
Latest round
- Series A
Last raised
- Sep 2025
Total raised
- Undisclosed
Investors
- 1
About Dianliang Napu
Founded in 2023 and based in Kunshan, China, Dianliang Napu focused on cutting-edge drug development. The company specializes in early-stage drug discovery, core technology development, and preclinical validation. Its pipeline includes proprietary compounds and platform technologies designed to address unmet medical needs. Dianliang Napu's revenue is generated through licensing of drug candidates, strategic R&D partnerships, and milestone-based agreements with pharmaceutical companies. Additional income may come from government grants and technology transfer arrangements.
Who invested in Dianliang Napu
1 investor across 1 round
See all investors in Dianliang Napu
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 25, 2025
Amount
Undisclosed
Investors
Questions about Dianliang Napu
Who invested in Dianliang Napu?
Dianliang Napu has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Dianliang Napu raised?
Dianliang Napu has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Dianliang Napu last raise money?
Dianliang Napu's most recent round on record is a Series A, in Sep 2025.
What does Dianliang Napu do?
Founded in 2023 and based in Kunshan, China, Dianliang Napu focused on cutting-edge drug development.
Where is Dianliang Napu headquartered?
Dianliang Napu is headquartered in Kunshan.
Which VCs invest in companies like Dianliang Napu?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Dianliang Napu's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Dianliang Napu? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.